Yahoo Poland Wyszukiwanie w Internecie

Search results

1. www.labiotech.eu › in-depth › copd-cure-breakthrough-treatmentsPromising cure for COPD: is a breakthrough within reach? -...

   www.labiotech.eu › in-depth › copd-cure-breakthrough-treatments

   • Zapisane w pamięci cache

   9 paź 2024 · Following recent approvals in the European Union (EU) and China, Duxipent’s U.S. approval is based on two phase 3 studies that showed the drug achieved significant reduction in COPD exacerbations, and also showed improvements in lung function and health-related quality of life compared to placebo.

2. time.com › 6903546New Advances in Managing COPD | TIME

   time.com › 6903546

   • Zapisane w pamięci cache

   18 mar 2024 · The newest drug therapies. Arguably the most buzzed about advancement in the COPD treatment landscape is the emergence of new biologic therapies, says Dr. Meilan Han, a professor of medicine in...

3. www.news.sanofi.us › 2024/09/27-Dupixent-approved-in-the-US-as-the-first-everDupixent approved in the US as the first-ever biologic medicine...

   www.news.sanofi.us › 2024/09/27-Dupixent-approved-in-the-US-as-the-first-ever

   • Zapisane w pamięci cache

   27 wrz 2024 · With today’s approval, Dupixent once again paves the way and becomes the first and only approved add-on biologic medicine for inadequately controlled COPD, giving patients living with this devastating disease the chance to look forward to the potential of improved breathing and a life with fewer exacerbations.”.

4. www.ajmc.com › view › fda-approves-dupilumab-as-first-biologic-treatment-for-copdFDA Approves Dupilumab as First Biologic Treatment for COPD

   www.ajmc.com › view › fda-approves-dupilumab-as-first-biologic-treatment-for-copd

   • Zapisane w pamięci cache

   27 wrz 2024 · The FDA approved dupilumab today as the first biologic treatment for patients with uncontrolled chronic obstructive pulmonary disease (COPD) and an eosinophilic phenotype to significantly...

5. www.copdfoundation.org › COPD360social › CommunityA New COPD Treatment is FDA Approved

   www.copdfoundation.org › COPD360social › Community

   • Zapisane w pamięci cache

   8 lip 2024 · Ensifentrine is a nebulized medication that relaxes airway muscles and reduces swelling in COPD patients. It is the first new class of drug for COPD in nearly 20 years and may improve breathing and prevent exacerbations.

6. www.drugs.com › newdrugs › fda-approves-ohtuvayre-ensifentrine-maintenance-chronicFDA Approves Ohtuvayre - Drugs.com

   www.drugs.com › newdrugs › fda-approves-ohtuvayre-ensifentrine-maintenance-chronic

   • Zapisane w pamięci cache

   Ohtuvayre is a first-in-class selective dual inhibitor of the enzymes phosphodiesterase 3 and phosphodiesterase 4 (“PDE3 and PDE4”) that combines bronchodilator and non-steroidal anti-inflammatory effects in one molecule.

7. www.webmd.com › lung › copdDupixent Gets FDA Approval for COPD - WebMD

   www.webmd.com › lung › copd

   • Zapisane w pamięci cache

   2 paź 2024 · Oct. 2, 2024 — The FDA has approved Regeneron and Sanofi’s drug Dupixent for patients with COPD (chronic obstructive pulmonary disease).